Eagle Pharmaceuticals Inc.
Eagle Pharmaceuticals Inc. appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1429-2012, Class I) was initiated on December 2, 2011.
Summary
- Total Recalls
- 1 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 3
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1429-2012 | Class I | Argatroban Injection 50 mg per 50ml (1 mg per ml) For Intravenous Infusion Only, a) Single Use Vial | December 2, 2011 |